tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

IRON Stock Latest News

Disc Medicine price target raised to $132 from $99 at Cantor Fitzgerald
The FlyDisc Medicine price target raised to $132 from $99 at Cantor Fitzgerald
11d ago
IRON
Disc Medicine’s Strategic Advances and Market Potential Drive Positive Analyst Rating
PremiumRatings
Disc Medicine’s Strategic Advances and Market Potential Drive Positive Analyst Rating
15d ago
IRON
Disc Medicine assumed with an Overweight at Morgan Stanley
PremiumThe Fly
Disc Medicine assumed with an Overweight at Morgan Stanley
22d ago
IRON
Disc Medicine price target raised to $75 from $73 at Scotiabank
PremiumThe Fly
Disc Medicine price target raised to $75 from $73 at Scotiabank
26d ago
IRON
Disc Medicine’s Strategic Advancements and Promising Pipeline Drive Buy Rating
PremiumRatings
Disc Medicine’s Strategic Advancements and Promising Pipeline Drive Buy Rating
26d ago
IRON
Promising Prospects for Disc Medicine: Buy Rating Backed by Bitopertin’s Potential and Strong Financial Health
PremiumRatingsPromising Prospects for Disc Medicine: Buy Rating Backed by Bitopertin’s Potential and Strong Financial Health
29d ago
IRON
Disc Medicine’s 2024 Financial Results and Clinical Progress
Premium
Company Announcements
Disc Medicine’s 2024 Financial Results and Clinical Progress
29d ago
IRON
Disc Medicine: Strong Financial and Clinical Position Supports Buy Rating
Premium
Ratings
Disc Medicine: Strong Financial and Clinical Position Supports Buy Rating
29d ago
IRON
Nvidia, Constellation Brands downgraded: Wall Street’s top analyst calls
PremiumThe Fly
Nvidia, Constellation Brands downgraded: Wall Street’s top analyst calls
30d ago
GS
FCX
Disc Medicine reports FY24 EPS ($3.96), consensus ($4.08)
PremiumThe Fly
Disc Medicine reports FY24 EPS ($3.96), consensus ($4.08)
30d ago
IRON
Disc Medicine sees cash runway into 2028
PremiumThe Fly
Disc Medicine sees cash runway into 2028
30d ago
IRON
Disc Medicine initiated with a Buy at TD Cowen
PremiumThe Fly
Disc Medicine initiated with a Buy at TD Cowen
30d ago
IRON
Disc Medicine 4.1M share Secondary priced at $55.00
PremiumThe FlyDisc Medicine 4.1M share Secondary priced at $55.00
2M ago
IRON
Disc Medicine price target raised to $73 from $70 at Scotiabank
Premium
The Fly
Disc Medicine price target raised to $73 from $70 at Scotiabank
2M ago
IRON
Disc Medicine announces $200M common stock offering
Premium
The Fly
Disc Medicine announces $200M common stock offering
2M ago
IRON
Disc Medicine Advances Bitopertin Trial for EPP
PremiumCompany Announcements
Disc Medicine Advances Bitopertin Trial for EPP
2M ago
8K
IRON
Disc Medicine announces feedback from Type C meeting with FDA
PremiumThe Fly
Disc Medicine announces feedback from Type C meeting with FDA
2M ago
IRON
Disc Medicine Highlights 2025 Strategy and Financial Updates
PremiumCompany Announcements
Disc Medicine Highlights 2025 Strategy and Financial Updates
3M ago
8K
IRON
Disc Medicine outlines recent pipeline, priorities for 2025
PremiumThe Fly
Disc Medicine outlines recent pipeline, priorities for 2025
3M ago
IRON
Disc Medicine price target raised to $90 from $79 at Stifel
PremiumThe FlyDisc Medicine price target raised to $90 from $79 at Stifel
4M ago
IRON
Disc Medicine presents clinical, translational data acroos portfolio at ASH meet
Premium
The Fly
Disc Medicine presents clinical, translational data acroos portfolio at ASH meet
4M ago
IRON
Disc presents clinical, translational data across portfolio at ASH meeting
Premium
The Fly
Disc presents clinical, translational data across portfolio at ASH meeting
4M ago
IRON

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >